All Posts
Survivor Thrives with the Support of Family and Community
In September 2023, Aileen’s life took an unexpected turn when she was diagnosed with cholangiocarcinoma. As a pediatric nurse and…
CCF Chicago Cholangiocarcinoma Symposium
Strength in Community, Hope in Research On September 27, 2024, the Cholangiocarcinoma Foundation hosted the Fifth Annual Regional Symposium at…
Biomarker Testing and Additional Opinions offers Strength and Hope
In the summer of 2021, Cynthia began experiencing mild heartburn—an unusual symptom for her. When she visited her family doctor,…
26.2 Miles for Friendship and a Cause
In a heartfelt gesture of dedication and friendship, devoted runner Andie Truitt is preparing to participate in the New York…
The Strati Family Continues #ChelleStrong with 2024 Golf Outing
The Strati family’s commitment to honoring the memory of their beloved Michelle “Chelle” Strati and raising awareness for cholangiocarcinoma (bile…
Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) (TOPAZ-1)
Study Name Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1) (TOPAZ-1)…
A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors
Study Name A Phase 2 Basket Study of Milademetan in Advanced/Metastatic Solid Tumors ClinicalTrials.gov Identifier (if applicable) NCT05012397 Clinical Trial Category (check all…
2024 Houston Cholangiocarcinoma Symposium
The 2024 Houston Cholangiocarcinoma Symposium is set to convene in Houston, drawing together leading experts, researchers, healthcare professionals, patients, and…
Michelle's Hot Peeps Beat CC Races Toward A Cure
The 7th Annual Michelle’s Hot Peeps Beat CC 5K Fun Run took place on August 10 at Murphy Park in…
Dr. Valle Honored as Professor Emeritus
The Cholangiocarcinoma Foundation is proud to announce that Dr. Juan Valle, Chief Medical Officer of the Cholangiocarcinoma Foundation (CCF), has…